Granules India gets USFDA nod for potassium chloride tablets used to treat hypokalemia

Granules has received marketing approval from the US Food and Drug Administration (USFDA) for Potassium Chloride extended release tablets USP in the strengths of 10 mEq (750 mg) and 20 mEq (1500 mg), the company said in a BSE filing.

from Industry-Economic Times https://ift.tt/34kOAPP
via IFTTT